Date: 4 November 2025
Venue: British Academy, 10-11 Carlton House Terrace, London SW1Y 5AH, United Kingdom
This workshop is designed to:
- Create a collaborative space for policymakers, researchers, patients, and funders to co-develop fair and practical solutions.
- Share real-world examples and international perspectives to promote meaningful interaction.
- Identify barriers and craft actionable, innovative solutions across sectors.
- Bridge grassroots insights with policy discussions to drive real progress in access to life-saving antibiotics.
Agenda for “Framing JUST solutions for ACCESS to treatment against AMR”
| Time | Topic | Speaker |
| 9.00 - 9.10 am | Welcome and program overview | Dr Shweta Singh Rajkumar Research Fellow ADVANCE-ID National University of Singapore |
| 9.10 - 9.25 am | Introduction - Need for equitable access to antibiotics | Dr Alexandra Cameron Senior Expert, AMR Division, WHO |
| 9.25 - 9.40 am | Setting the scene - Barriers to accessing novel antibiotics in countries with high burden of bacterial antimicrobial resistant infections | Dr Mo Yin Deputy Director ADVANCE-ID National University of Singapore |
| 9.40 - 9.45 am | Patient’s experiences in accessing new antibiotics | Ms Jasmine Zea Radha AMR Patient Advocate Malaysia |
| 9.45 - 10.30 am | Case studies | |
| 9.45 - 10.00 am | Strategies on enabling access to treatment in local context | Dr Inke Nadia Assistant Professor Universitas Sumatera Utara Medan, Indonesia |
| 10.00 - 10.15 am | Access to new medicines, working within the limitations of a constrained healthcare ecosystem | Dr Sotharith Bory Chief of Medicines Department and ID Unit - Calmette Hospital, Cambodia |
| 10.15 - 10.30 am | Challenges in commercialising and marketing new antibiotics - Cefiderocol | Ms Takuko Sawada Director, Vice President of the Board for Shionogi & Co. Ltd Osaka, Japan |
| 10.30 - 10.45 am | Break | |
| 10.45 - 11.30 am | Panel discussion 1 - Framing the antibiotic access issues and identifying the bottlenecks |
|
| 11.30 am - 12.30 pm | Group discussion 1 | |
| 12.30 pm - 1.30 pm | Lunch | |
| 1.30 - 1.45 pm | Working with WHO SECURE in Southeast Asia | Dr Rahela Ambaras Khan Head of Pharmacotherapy Services Department of Pharmacy Hospital Kuala Lumpur, Malaysia |
| 1.45 - 2.00 pm | GARDP - Implementing the cefiderocol project in partnership with Shionogi, CHAI, Orchid Pharma | Mr Rahul Dwivedi Serious Bacterial Infections Access Leader GARDP, Geneva |
| 2.00 - 2.15 pm | AMR Action Fund supporting antimicrobial innovation | Dr Henry Skinner Chief Executive Officer AMR Action Fund |
| 2.15 - 3.15 pm | Panel discussion - Mapping stakeholders and recognising immediate actionables |
|
| 3.15 - 3.30 pm | Break | |
| 3.30 - 4.30 pm | Group discussion 2 | |
| 4.30 - 4.40 pm | Closing remarks | Dr Mo Yin Deputy Director ADVANCE-ID National University of Singapore |
